Please login to the form below

Not currently logged in
Email:
Password:

Former Sanofi chairman joins Pertinax Pharma

Nigel Brooksby will drive the commercialisation of the company as chairman

Pertinax Pharma has appointed Nigel Brooksby as its new chairman, a role that will see him help drive the commercialisation of the company by assisting in corporate strategic and business developments.

During his 38-year career in the pharmaceutical industry, Brooksby has served in roles such from medical sales representative to chairman.

He has held senior appointments in Wellcome - now GSK, Pfizer and as chairman and MD at Sanofi UK and Ireland and as a member of the Sanofi Executive Committee in Europe and America.

Michele Barbour, founder and chief scientific officer, Pertinax Pharma, said: “We are delighted that Nigel has chosen to join our board.

“His unparalleled experience in the pharmaceutical and related industries, his long established industry connections and his experience with early stage biomedical companies make him the ideal individual for the tasks at hand.

“We look forward to Nigel playing a pivotal role in Pertinax Pharma’s continued development as bring the benefits of our patented and commercialised Pertinax technology to the healthcare sector.”

24th November 2017

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Six Degrees Medical Consulting

For over a decade, our medical communication services have helped pharmaceutical companies optimize their brand, disease and corporate objectives. Building...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics